| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, R&D | See Remarks
1 company
Bergstrom Donald A is a President, R&D at Relay Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $5.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27, 2024 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 648 | $6.26 | $4,056.48 | -0.1% | +12.1% | -47.6% | |
| Apr 29, 2024 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 2,686 | $6.38 | $17,136.68 | -0.5% | +24.7% | -53.0% | |
| Mar 27, 2024 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 765 | $7.70 | $5,890.50 | -0.1% | -17.4% | -63.4% | |
| Jan 29, 2024 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 3,178 | $9.64 | $30,635.92 | -0.6% | -33.7% | -53.5% | |
| Dec 27, 2023 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 977 | $11.51 | $11,245.27 | -0.4% | -33.6% | -61.0% | |
| Oct 30, 2023 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 3,451 | $6.03 | $20,809.53 | -1.4% | +59.6% | -5.3% | |
| Sep 27, 2023 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 648 | $8.38 | $5,430.24 | -0.3% | +39.0% | -10.4% | |
| Jul 28, 2023 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 2,683 | $11.80 | $31,659.40 | -1.1% | -48.2% | -26.9% | |
| Jun 27, 2023 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 647 | $12.12 | $7,841.64 | -0.3% | -33.1% | -50.2% | |
| Apr 28, 2023 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 1,383 | $11.16 | $15,434.28 | -0.6% | +2.9% | -44.0% |